REVB - REVELATION BIOSCIENCES, INC.
1.24
-0.010 -0.806%
Share volume: 36,194
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.25
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 09-23-2024 | 09-23-2024 | 11-08-2024 | 03-06-2025 | 05-08-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 14.702 M | 12.270 M | 6.740 M | 6.622 M | 3.970 M | 12.856 M | 11.583 M | |
| Current Assets | 14.624 M | 12.199 M | 6.659 M | 6.566 M | 3.928 M | 12.832 M | 10.812 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 14.552 M | 12.073 M | 6.541 M | 6.499 M | 3.705 M | 12.708 M | 10.700 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 77.994 K | 70.774 K | 81.242 K | 56.332 K | 42.390 K | 23.919 K | 18.067 K | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 753.229 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 14.702 M | 12.270 M | 6.740 M | 6.622 M | 3.970 M | 12.856 M | 11.583 M | |
| Total liabilities | 5.228 M | 11.129 M | 4.067 M | 1.914 M | 1.090 M | 1.855 M | 2.722 M | |
| Total current liabilities | 5.228 M | 11.129 M | 4.067 M | 1.914 M | 1.090 M | 1.855 M | 1.998 M | |
| Accounts Payable | 1.682 M | 1.281 M | 3.127 M | 783.621 K | 625.058 K | 1.035 M | 577.501 K | |
| Other liabilities | 15.260 K | 10.844 K | 4.803 K | 2.246 K | 829.000 | 175.000 | 723.771 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 15.260 K | 10.844 K | 4.803 K | 2.246 K | 829.000 | 175.000 | 723.771 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.473 M | 1.140 M | 2.674 M | 4.708 M | 2.881 M | 11.002 M | 8.861 M | |
| Common stock | 37.622 M | 37.679 M | 41.454 M | 45.214 M | 45.437 M | 57.910 M | 58.280 M | |
| Retained earnings | -28.149 M | -36.538 M | -38.780 M | -40.506 M | -42.557 M | -46.908 M | -49.419 M |